Temperature Measurement in Surgical and Intensive Care Patients - Comparison of Four Measurement Methods

NCT ID: NCT02220101

Last Updated: 2023-01-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

95 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-04-30

Study Completion Date

2023-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comparison of four methods for measuring temperature perioperatively in patients scheduled for laparoscopic surgery and intensive care patients who are hypo-, normo-and hyper terme; Bladder Monitoring, Nasopharyngeal, SpotOn TM, Zero heat flux method and Temporal Scanner. The study is a single-center, observational study carried out by the Central Surgical and Intensive Section at Vestfold Hospital Trust.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Issues

* Perioperative hypothermia is associated with several serious complications and therefore most likely to be avoided. Monitoring of body temperature is therefore required perioperatively .
* There are in the literature concerns that some methods of measuring temperature perioperatively is accurate enough and whether they reflect core temperature adequate.
* Some authors have questioned whether temporal scanner (TS ) - and nasopharynx ( NP) - measurements are accurate enough to measure the actual core temperature. Much of the research on TS measurements have been done on children and newborns in an intensive setting, but little perioperatively .

A total of 120 patients will be included ; 60 at Central Operations and 60 at Intensive Section at the Vestfold Hospital Trust. Duration of inclusion will be approximately one year . Starting around January 2014. The study emanates from Vestfold Hospital Trust and was designed by Espen Lindholm who is responsible for the project , Camilla B Norén who is principal investigator and project manager. Kjetil G Ringdal , Karl - André Wian and Knut Arvid Kirkebøen (University Hospital of Oslo ) are supervisors. The study is supported by research, Vestfold Hospital Trust and 3M Company Norway (study material ) and it is applied Regional Ethics Committee. Patients will not get different treatment than standard treatment in hospital and it causes no follow-up calls or hospital visits. All patients (if possible) give written consent for participation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypothermia Hyperthermia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Surgical Patient group:

* \> 18 years
* ASA 1-3
* Laparoscopic surgery
* Elective surgery

Intensive Patient group:

* \> 18 years
* Defined as intensive patient
* ASA 1-5

Exclusion Criteria

Surgical Patient group:

* BMI\> 30 kg/m2
* No bladder (ileum-bladder)
* Known malignant hyperthermia
* Malformations of the face that prevents nasopharynx and temporal scanner measurements
* Patient is participating in another study that may influence the results of the Tempstudy
* The patient is not competent to give consent, eg severe dementia
* The patient INR\> 2.0 and / or Trc \<50

Intensive Patient group:

* BMI\> 30 kg/m2
* No bladder (ileum-bladder)
* Malformations of the face that prevents nasopharynx and temporal scanner measurements
* Hypothermic patient below 32 ° C (bladder temperature)
* Hyperterm patient over 40 ° C (bladder temperature)
* Active cooling of the bladder
* The patient is under ongoing cooling or heating
* Patient is participating in another study that may influence the results of the Tempstudy
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

3M

INDUSTRY

Sponsor Role collaborator

Sykehuset i Vestfold HF

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Espen Lindholm

Chief of Department of Anesthesiology section

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Espen Lindholm, M.D.

Role: STUDY_DIRECTOR

Departement of Anesthesiology, Vestfold Hospital Trust

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Vestfold Hospital Trust

Tønsberg, , Norway

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Norway

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1A

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.